Colchicine in coronary disease: another renaissance of an ancient drug

Aernoud T L Fiolet^{1

2

3

4}, Peter L Thompson^{5

6

7}, Arend Mosterd^{3

4}

Affiliations

¹ Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
² Netherlands Heart Institute, Utrecht, The Netherlands.
³ Department of Cardiology, Meander Medical Centre, P.O. Box 1502, 3800 BM Amersfoort, The Netherlands.
⁴ The Dutch Network for Cardiovascular Research, Utrecht, The Netherlands.
⁵ GenesisCare Western Australia, Perth, Western Australia, Australia.
⁶ Department of Cardiology, Sir Charles Gairdner Hospital, and the Faculty of Health and Medical Sciences, Perth, Western Australia, Australia.
⁷ Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.

Aernoud T L Fiolet et al. Cardiovasc Res. 2021.

. 2021 Jan 1;117(1):e4-e6.

doi: 10.1093/cvr/cvaa342.

Aernoud T L Fiolet^{1

2

3

4}, Peter L Thompson^{5

6

7}, Arend Mosterd^{3

4}

¹ Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
² Netherlands Heart Institute, Utrecht, The Netherlands.
³ Department of Cardiology, Meander Medical Centre, P.O. Box 1502, 3800 BM Amersfoort, The Netherlands.
⁴ The Dutch Network for Cardiovascular Research, Utrecht, The Netherlands.
⁵ GenesisCare Western Australia, Perth, Western Australia, Australia.
⁶ Department of Cardiology, Sir Charles Gairdner Hospital, and the Faculty of Health and Medical Sciences, Perth, Western Australia, Australia.
⁷ Harry Perkins Institute of Medical Research, Nedlands, Western Australia, Australia.

No abstract available

Keywords: Clinical trials; Colchicine; Coronary disease; Inflammation.

MeSH terms